EDP Sciences logo
Search
Menu
All issues Volume 35 / No 2 (March-April 2004) Vet. Res., 35 2 (2004) 213-224 References
Free Access
Issue
Vet. Res.
Volume 35, Number 2, March-April 2004
Page(s) 213 - 224
DOI https://doi.org/10.1051/vetres:2004004
How to cite this article Vet. Res. (2004) 213-224
References of Vet. Res. 35 213-224
  1. Akgul C., Moulding D.A., Edwards S.W., Molecular control of neutrophil apoptosis, FEBS Lett. 487 (2001) 318-322 [CrossRef] [PubMed].
  2. Bertrand R., Solary E., O'Connor P., Kohn K.W., Pommier Y., Induction of a common pathway of apoptosis by staurosporine, Exp. Cell Res. 211 (1994) 314-321 [CrossRef] [PubMed].
  3. Brown S.B., Savill J., Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes, J. Immunol. 162 (1999) 480-485 [PubMed].
  4. Budd R.C., Activation-induced cell death, Curr. Opin. Immunol. 13 (2001) 356-362 [CrossRef] [PubMed].
  5. Canetti C., Silva J.S., Ferreira S.H., Cunha F.Q., Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation, Br. J. Pharmacol. 134 (2001) 1619-1628 [PubMed].
  6. Chin A.C., Morck D.W., Merrill J.K., Ceri H., Olson M.E., Read R.R., Dick P., Buret A.G., Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs, Am. J. Vet. Res. 59 (1998) 765-771 [PubMed].
  7. Chin A.C., Lee W.D., Murrin K.A., Morck D.W., Merrill J.K., Dick P., Buret A.G., Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages, Antimicrob. Agents Chemother. 44 (2000) 2465-2470 [CrossRef] [PubMed].
  8. Clinkenbeard K.D., Clarke C.R., Hague C.M., Clinkenbeard P., Srikumaran S., Morton R.J., Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro, J. Leukoc. Biol. 56 (1994) 644-649 [PubMed].
  9. Cox G., Crossley J., Xing Z., Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo, Am. J. Respir. Cell Mol. Biol. 12 (1995) 232-237 [PubMed].
  10. Crooks S.W., Stockley R.A., Leukotriene B4, Int. J. Biochem. Cell Biol. 30 (1998) 173-178 [CrossRef] [PubMed].
  11. Fadok V.A., Bratton D.L., Frasch S.C., Warner M.L., Henson P.M., The role of phosphatidylserine in recognition of apoptotic cells by phagocytes, Cell Death Differ. 5 (1998) 551-562 [CrossRef] [PubMed].
  12. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J. Clin. Invest. 101 (1998) 890-898 [PubMed].
  13. Fajt V.R., Apley M.D., Roth J.A., Frank D.E., Brogden K.A., Skogerboe T.L., Shostrom V.K., Chin Y.-L., The effects of danofloxacin and tilmicosin on neutrophil function and lung consolidation in beef heifer calves with induced Pasteurella (Mannheimia) haemolytica pneumonia, J. Vet. Pharmacol. Therap. 26 (2003) 173-179.
  14. Goubau S., Morck D.W., Buret A., Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica, Can. J. Vet. Res. 64 (2000) 238-242 [PubMed].
  15. Hand W.L., Hand D.L., King-Thompson N.L., Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes, Antimicrob. Agents Chemother. 34 (1990) 863-870 [PubMed].
  16. Healy D.P., Silverman P.A., Neely A.N., Holder I.A., Babcock G.E., Effect of antibiotics on polymorphonuclear neutrophil apoptosis, Pharmacotherapy 22 (2002) 578-585 [PubMed].
  17. Henderson W.R. Jr., The role of leukotrienes in inflammation, Ann. Intern. Med. 121 (1994) 684-697 [PubMed].
  18. Henricks P.A., Binkhorst G.J., Drijver A.A., Nijkamp F.P., Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes, Infect. Immun. 60 (1992) 3238-3243 [PubMed].
  19. Hubbard R.C., Fells G., Gadek J., Pacholok S., Humes J., Crystal R.G., Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages, J. Clin. Invest. 88 (1991) 891-897 [PubMed].
  20. Inamura K., Ohta N., Fukase S., Kasajima N., Aoyagi M., The effects of erythromycin on human peripheral neutrophil apoptosis, Rhinology 38 (2000) 124-129 [PubMed].
  21. Itkin I.H., Menzel M.L., The use of macrolide antibiotic substances in the treatment of asthma, J. Allergy 45 (1970) 146-162 [PubMed].
  22. Jacques M., Mikael L.G., Virulence factors of Pasteurellaceae, formidable animal pathogens, ASM News 68 (2002) 174-179.
  23. Kalechman Y., Strassmann G., Albeck M., Sredni B., Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101, J. Immunol. 161 (1998) 3536-3542 [PubMed].
  24. Kawasaki S., Takizawa H., Ohtoshi T., Takeuchi N., Kohyama T., Nakamura H., Kasama T., Kobayashi K., Nakahara K., Morita Y., Yamamoto K., Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro, Antimicrob. Agents Chemother. 42 (1998) 1499-1502 [PubMed].
  25. Kawashima M., Yatsunami J., Fukuno Y., Nagata M., Tominaga M., Hayashi S., Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury, Lung 180 (2002) 73-89 [PubMed].
  26. Khair O.A., Devalia J.L., Abdelaziz M.M., Sapsford R.J., Davies R.J., Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells, Eur. Respir. J. 8 (1995) 1451-1457 [PubMed].
  27. Kikuchi T., Hagiwara K., Honda Y., Gomi K., Kobayashi T., Takahashi H., Tokue Y., Watanabe A., Nukiwa T., Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors, J. Antimicrob. Chemother. 49 (2002) 745-755 [CrossRef] [PubMed].
  28. Koch C.C., Esteban D.J., Chin A.C., Olson M.E., Read R.R., Ceri H., Morck D.W., Buret A.G., Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae, J. Antimicrob. Chemother. 46 (2000) 19-26 [CrossRef] [PubMed].
  29. Lakritz J., Tyler J.W., Marsh A.E., Romesburg-Cockrell M., Smith K., Holle J.M., Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases, Vet. Ther. 3 (2002) 7-21 [PubMed].
  30. Leite F., O'Brien S., Sylte M.J., Page T., Atapattu D., Czuprynski C.J., Inflammatory cytokines enhance the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood neutrophils in vitro, Infect. Immun. 70 (2002) 4336-4343 [CrossRef] [PubMed].
  31. Li Y., Azuma A., Takahashi S., Usuki J., Matsuda K., Aoyama A., Kudoh S., Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice, Chest 122 (2002) 2137-2145 [CrossRef] [PubMed].
  32. Lin H.C., Wang C.H., Liu C.Y., Yu C.T., Kuo H.P., Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils, Respir. Med. 94 (2000) 654-660 [PubMed].
  33. Morck D.W., Merrill J.K., Gard M.S., Olson M.E., Nation P.N., Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin, Can. J. Vet. Res. 61 (1997) 187-192 [PubMed].
  34. Narayanan S.K., Nagaraja T.G., Chengappa M.M., Stewart G.C., Leukotoxins of gram-negative bacteria, Vet. Microbiol. 84 (2002) 337-356 [CrossRef] [PubMed].
  35. Oishi K., Sonoda F., Kobayashi S., Iwagaki A., Nagatake T., Matsushima K., Matsumoto K., Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases, Infect. Immun. 62 (1994) 4145-4152 [PubMed].
  36. Partrick D.A., Moore E.E., Moore F.A., Barnett C.C., Silliman C.C., Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils, J. Trauma 43 (1997) 297-303 [PubMed].
  37. Plewig G., Schopf E., Anti-inflammatory effects of antimicrobial agents: an in vivo study, J. Invest. Dermatol. 65 (1975) 532-536 [PubMed].
  38. Saitoh A., Kawanabe T., Weidong H., Kayagaki N., Kawamura T., Yagita H., Okumura K., Shimada S., Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: the skin as a retinoide-inducible immune privilege site, J. Invest. Dermatol. 115 (2000) 154-161 [CrossRef] [PubMed].
  39. Savill J.S., Henson P.M., Haslett C., Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism, J. Clin. Investig. 84 (1989) 1518-1527.
  40. Scorneaux B., Shryock T.R., Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells, J. Dairy Sci. 82 (1999) 1202-1212 [PubMed].
  41. Sibille Y., Reynolds H.Y., Macrophages and polymorphonuclear neutrophils in lung defense and injury, Am. Rev. Respir. Dis. 141 (1990) 471-501 [PubMed].
  42. Siegel R.M., Chan F.K., Chun H.J., Lenardo M.J., The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity, Nat. Immunol. 1 (2000) 469-474 [CrossRef] [PubMed].
  43. Squier M.K., Sehnert A.J., Cohen J.J., Apoptosis in leukocytes, J. Leukoc. Biol. 57 (1995) 2-10 [PubMed].
  44. Tsuchihashi Y., Oishi K., Yoshimine H., Suzuki S., Kumatori A., Sunazuka T., Omura S., Matsushima K., Nagatake T., Fourteen-member macrolides suppress interleukin-8 production but do not promote apoptosis of activated neutrophils, Antimicrob. Agents Chemother. 46 (2002) 1101-1104 [CrossRef] [PubMed].
  45. Villagrasa V., Berto L., Cortijo J., Perpina M., Sanz C., Morcillo E.J., Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes, Gen. Pharmacol. 29 (1997) 605-609 [CrossRef] [PubMed].
  46. Weinhold U., Hofmann W., Mulling C., Budras K.-D., Untersuchungen von Bronchialzellsedimenten lungenkranker Kaelber waehrend der Behandlung mit den Antibiotika Tilmicosin und Ceftiofur auf das Vorkommen der Apoptosis der neutrophilen Granulozyten, Tierarztl. Umsch. 58 (2003) 191-199.
  47. Woolhouse I.S., Bayley D.L., Stockley R.A., Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8, Thorax 57 (2002) 709-714 [CrossRef] [PubMed].
  48. Yakes F.M., Wamil B.D., Sun F., Yan H.P., Carter C.E., Hellerqvist C.G., CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis, Cancer Res. 60 (2000) 5740-5746 [PubMed].
  49. Yoo J., Stone R.T., Beattie C.W., Cloning and characterization of the bovine Fas, DNA Cell Biol. 15 (1996) 227-234 [PubMed].
  50. Young I.T., Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources, J. Histochem. Cytochem. 25 (1977) 935-941 [PubMed].